Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
NCT ID NCT04080492
First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time
Summary
Researchers at the Cleveland Clinic are following 380 adults with hypertrophic cardiomyopathy, thoracic aortic dilatation, or radiation-induced heart disease. Participants complete a detailed survey at the start and again nine months later. The survey measures global, physical, emotional, social, and spiritual health, plus self-efficacy and resilience. The goal is to see how these conditions affect daily life over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cardiac Quality of Life survey
- What this could lead to
- If the survey captures meaningful changes, it could help doctors better understand and address the daily challenges of living with these heart conditions.
- What could go wrong
- This observational study cannot prove cause and effect, and the findings may not apply to all patients with these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
380 people
The number who actually took part.
- Started
-
Aug 2019
- Finished
-
Sep 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study will include first-time patients being seen at the Cleveland Clinic whose information will be collected in-person and remotely.
- Ages
-
18 to 70 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18-70 at time of consent with a confirmed diagnosis of HCM, TAD, and/or RIHD being seen at CC Main Campus for a comprehensive clinical cardiac evaluation (i.e. physician, surgeon, nurse practitioner, geneticist, testing, imaging, etc) to define treatment plan for either diagnosis as per Cleveland Clinic provider. * Patient or an individual in their social support network has the equipment (phone, computer, tablet) and internet connection to complete the emailed follow-up questionnaires. Exclusion Criteria: * Previously had surgery or plans to have surgery (full/mini sternotomy or endovascular) in the next nine months for HCM or TAD. * Inability or unwillingness to comply with study requirements in the opinion of the investigator. * Inability to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart disease caused by ionising radiation are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Fewer dialysis sessions: can Twice-Weekly work as well?
- Two ways to rebuild a tongue: which one leaves patients better off?
- Can a triage checklist ease pain months after emergency surgery?